MedTrace Logo

Early Treatment of Post-stroke Spasticity With Botulinum Toxin

NCT04404868 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 86

Last updated 2020-05-28

No results posted yet for this study

Summary

This was a multicentric observational study with the aim to evaluate the effect of early treatment with botulinum toxin type A (BoNT-A) on post-stroke spasticity in adult patients. All patients enrolled (86 patients) after a baseline clinical assessment (modified Ashworth scale, motricity index, Fughl Meyer assessment and modified Rankin' scale) undergoes to a BoNT-A injection following the evidence-based clinical practice. Subsequently, at 4, 12 and 24 weeks they underwent the same clinical evaluation as a follow-up. Results are under statistical evaluation.

Conditions

Interventions

OTHER

Normal clinical practice

There are no experimental interventions. The procedures are in line with normal clinical practice.

Sponsors & Collaborators

  • Universita di Verona

    lead OTHER

Principal Investigators

  • Nicola Smania, MD · Universita di Verona

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-07-27
Primary Completion
2018-12-31
Completion
2018-12-31

Countries

  • Italy

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04404868 on ClinicalTrials.gov